John J. Gormally, Chief Executive Officer at Akers Biosciences Inc (AKER), bought 2,500 shares at $2.23 ($6K) on 2016-05-24, disclosed to the SEC on 2016-05-24.
Open-market purchase of $6k AKER by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.19 | 69 | $151 | 2.7% |
| 2 | $2.20 | 1,000 | $2K | 39.5% |
| 3 | $2.23 | 100 | $223 | 4.0% |
| 4 | $2.24 | 200 | $448 | 8.0% |
| 5 | $2.25 | 1,131 | $3K | 45.7% |
| Total | $2.23 avg | 2,500 |
| $6K |
| 100% |